Broadcast Date: Friday, March 31, 2023
from 12:00 pm to 1:00 pm (ET)

Overview:

A “skinny label” is a label on a generic pharmaceutical product that “carves out” (eliminates) the listing of an indication or disease for which the reference drug has been approved. Generic manufacturers use skinny labels to try to avoid “inducing” infringement of branded patents that claim the treatment of the carved-out diseases. But sometimes infringement can still be found. In what many see as a pivotal case – Glaxo v. Teva – the Federal Circuit found infringement despite a skinny label. The panelists will discuss the law of induced infringement before and after Glaxo v. Teva; what that case portends for the future; and what the U.S. Supreme Court may or may not do with the case.

  1. The Law of Infringement by Inducement Generally
  2. Inducement in the Context of Hatch-Waxman Cases – Pre-Glaxo v. Teva
  3. Glaxo v. Teva at the District Court Case
  4. Glaxo v. Teva at the Federal Circuit
  5. Supreme Court Petition for Certiorari
  6. Perspectives – Discussion

Credit:

Course Level:

Intermediate

 

Advance Preparation:

Print and review course materials

 

Method of Presentation:

On-Demand Webcast

 

Prerequisite: 

General knowledge of patent laws

 

Course Code:

1410566

 

NY Category of CLE Credit:

Areas of Professional Practice

 

Total Credit:

1.0 CLE

Speaker Panel:

Jason A. Lief, Partner
27 Years of Experience in Patent and
Intellectual Property Cases

Windels Marx Lane & Mittendorf, LLP

Jason Lief is a premier patent trial lawyer with 27 years of experience. He has litigated and tried dozens of major patent and other intellectual property cases on behalf of some of the world’s most innovative and dynamic companies, often involving billion-dollar products. Applying his legal and scientific training, Jason has established a reputation for winning outcomes and courtroom excellence.

Jason’s cases include major Hatch-Waxman pharmaceutical litigations (Zantac®, Wellbutrin®, Wellbutrin SR®, Wellbutrin XL®, Ceftin®, Intuniv®, Vyvanse®, Oxtellar XR®, Angiomax®, and Lialda®), as well as biotech, chemical, and consumer product patent cases. Jason has also litigated trade secret, trademark, copyright, and IP contract disputes.

Pablo Hendler, Partner
Potomac Law Group, PLLC

Pablo Hendler has counseled clients for nearly 30 years on intellectual property matters.  Pablo’s focus has been on life science patent litigation, including Hatch-Waxman, biologic, and medical device cases.  His clients have consistently praised him as an “excellent lawyer” and a “sharpshooting” litigator, particularly for his “sterling” work in ANDA litigations. They are comforted by his “seen-and-done-it-all experience.”  Pablo is also actively involved in pro bono immigration work.

Agenda:

Jason A. LiefPartner

Windels Marx Lane & Mittendorf, LLP

and

Pablo HendlerPartner

Potomac Law Group, PLLC

  1. The Law of Infringement by Inducement Generally
  2. Inducement in the Context of Hatch-Waxman Cases – Pre-Glaxo v. Teva
  3. Glaxo v. Teva at the District Court Case
  4. Glaxo v. Teva at the Federal Circuit
  5. Supreme Court Petition for Certiorari
  6. Perspectives – Discussion

Date & Time:

Friday, March 31, 2023

12:00 pm to 1:00 pm (ET)

Who Should Attend:

  • Intellectual Property Lawyers/Counsel
  • Biotechnology/Pharmaceutical Lawyers
  • Patent Attorneys
  • Patent Licensing Attorneys
  • FDA Attorneys
  • Patent Managers
  • Patent Examiners
  • General Counsel from Biotechnology/Pharmaceutical Industries
ImageNameCategory
Preventing Ransomware Attacks: A Practical Guide to Enhancing IT Security and Resiliency,
Speaker Preferred Package (Online Payment)
Sponsorship
Asbestos Litigation: Demystifying Trends, Developments, and Defense Strategies,
New York Online CLE Bundle
Pennsylvania Online CLE Bundle
California Online CLE Bundle
Supercharging Privilege Review With AI, Analytics, and Automation,
The Hows and Whys of Child Abuse Reporting: A Comprehensive Ethical Guide for Lawyers,
Understanding R&D Tax Credits and Amortization: Navigating Changes and Maximizing Benefits,
Maximizing Your Innovation ROI: R&D Tax Credits in 2024 and Beyond,
Winning Patent Litigation: Essential Strategies and Tactics,
Cartel Investigations: A Blueprint for Defense,
Demystifying Economic Sanctions: Strategies for Success in a Global Economy,
Antitrust 'No-Poach' Agreement Enforcement: Key Focus Areas in 2024,
Practical Trademark Perspectives from U.S. and Canadian Counsel,
Effectively Manage KYC Compliance: Keep Up with the Times by Getting Back to Basics,
OFAC Regulations and the Economic Sanctions Compliance Programs: Best Practices,
'Zombie' LIBOR for USD Contracts: Navigating the Critical Issues, ,
Calculating Lost Profits in Construction Claims: A Practical Guide,
False Claims Act and COVID-19 Implications: Key Considerations and Best Practices, ,

SPEAKERS

Jason A. LiefPartner
27 Years of Experience in Patent and
Intellectual Property Cases
Windels Marx Lane & Mittendorf, LLP
Pablo HendlerPartner
Potomac Law Group, PLLC

SUBSCRIPTION PACKAGES

ALL-ACCESS PASS

View Details

CLE LAW MONTHLY

View Details

CPE FINANCE MONTHLY

View Details

Join Over 160,000 Professionals Empowering Their Careers

Learn anywhere from over 3000+ live and recorded CLE, CPE & Technology Webcasts.